171 related articles for article (PubMed ID: 26875794)
1. CAV1 Prevents Gallbladder Cholesterol Crystallization by Regulating Biosynthesis and Transport of Bile Salts.
Xu G; Li Y; Jiang X; Chen H
J Cell Biochem; 2016 Sep; 117(9):2118-27. PubMed ID: 26875794
[TBL] [Abstract][Full Text] [Related]
2. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
Uppal H; Zhai Y; Gangopadhyay A; Khadem S; Ren S; Moser JA; Xie W
Hepatology; 2008 Apr; 47(4):1331-42. PubMed ID: 18318438
[TBL] [Abstract][Full Text] [Related]
3. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D
Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505
[No Abstract] [Full Text] [Related]
4. Adeno-associated virus-based caveolin-1 delivery via different routes for the prevention of cholesterol gallstone formation.
Li S; Chen H; Jiang X; Hu F; Li Y; Xu G
Lipids Health Dis; 2022 Oct; 21(1):109. PubMed ID: 36303150
[TBL] [Abstract][Full Text] [Related]
5. PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts.
He J; Nishida S; Xu M; Makishima M; Xie W
Gastroenterology; 2011 Jun; 140(7):2095-106. PubMed ID: 21354151
[TBL] [Abstract][Full Text] [Related]
6. Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation.
Cheng S; Zou M; Liu Q; Kuang J; Shen J; Pu S; Chen L; Li H; Wu T; Li R; Li Y; Jiang W; Zhang Z; He J
Am J Pathol; 2017 Apr; 187(4):808-818. PubMed ID: 28283178
[TBL] [Abstract][Full Text] [Related]
7. Claudin 2 deficiency reduces bile flow and increases susceptibility to cholesterol gallstone disease in mice.
Matsumoto K; Imasato M; Yamazaki Y; Tanaka H; Watanabe M; Eguchi H; Nagano H; Hikita H; Tatsumi T; Takehara T; Tamura A; Tsukita S
Gastroenterology; 2014 Nov; 147(5):1134-45.e10. PubMed ID: 25068494
[TBL] [Abstract][Full Text] [Related]
8. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation.
Wang HH; Afdhal NH; Gendler SJ; Wang DQ
J Lipid Res; 2004 Mar; 45(3):438-47. PubMed ID: 14703511
[TBL] [Abstract][Full Text] [Related]
10. Activation of Estrogen Receptor G Protein-Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice.
Wang HH; de Bari O; Arnatt CK; Liu M; Portincasa P; Wang DQ
Hepatology; 2020 Dec; 72(6):2077-2089. PubMed ID: 32112420
[TBL] [Abstract][Full Text] [Related]
11. Transgenic overexpression of Niemann-Pick C2 protein promotes cholesterol gallstone formation in mice.
Acuña M; González-Hódar L; Amigo L; Castro J; Morales MG; Cancino GI; Groen AK; Young J; Miquel JF; Zanlungo S
J Hepatol; 2016 Feb; 64(2):361-369. PubMed ID: 26453970
[TBL] [Abstract][Full Text] [Related]
12. Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice.
de Bari O; Wang TY; Liu M; Portincasa P; Wang DQ
J Lipid Res; 2015 Sep; 56(9):1691-700. PubMed ID: 26152119
[TBL] [Abstract][Full Text] [Related]
13. Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice.
Wang HH; Portincasa P; Liu M; Tso P; Samuelson LC; Wang DQ
Biochim Biophys Acta; 2010 Feb; 1801(2):138-46. PubMed ID: 19836465
[TBL] [Abstract][Full Text] [Related]
14. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
Wang HH; Portincasa P; Wang DQ
Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
[TBL] [Abstract][Full Text] [Related]
15. Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in mice.
Xu GQ; Xu CF; Chen HT; Liu S; Teng XD; Xu GY; Yu CH
World J Gastroenterol; 2014 Jul; 20(28):9513-8. PubMed ID: 25071346
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity.
Zhang Z; Du Z; Liu Q; Wu T; Tang Q; Zhang J; Huang C; Huang Y; Li R; Li Y; Zhao Y; Zhang G; Zhou J; Huang H; Fang Z; He J
Metabolism; 2021 May; 118():154728. PubMed ID: 33581130
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of Niemann-Pick C1 protein protects against diet-induced gallstone formation in mice.
Morales MG; Amigo L; Balboa E; Acuña M; Castro J; Molina H; Miquel JF; Nervi F; Rigotti A; Zanlungo S
Liver Int; 2010 Jul; 30(6):887-97. PubMed ID: 20408952
[TBL] [Abstract][Full Text] [Related]
18.
Xie Y; Cifarelli V; Pietka T; Newberry EP; Kennedy SM; Khalifeh-Soltani A; Clugston R; Atabai K; Abumrad NA; Davidson NO
J Lipid Res; 2017 Aug; 58(8):1692-1701. PubMed ID: 28634191
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet.
Han T; Lv Y; Wang S; Hu T; Hong H; Fu Z
Lipids Health Dis; 2019 Dec; 18(1):218. PubMed ID: 31829191
[TBL] [Abstract][Full Text] [Related]
20. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet.
Amigo L; Quiñones V; Mardones P; Zanlungo S; Miquel JF; Nervi F; Rigotti A
Gastroenterology; 2000 Apr; 118(4):772-9. PubMed ID: 10734029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
